Instil Bio (TIL) Construction in Progress (2020 - 2022)
Instil Bio (TIL) posted Construction in Progress of $104.0 million for Q4 2022, up 55.22% on a QoQ basis from $67.0 million in Q4 2021, and up 55.22% year-over-year from $67.0 million in Q4 2021.
Analysis
Instil Bio (TIL) Construction in Progress (2020 - 2022) Analysis & Trends
Instil Bio has reported Construction in Progress for 3 years, with the latest figure at $104.0 million in Q4 2022.
- On a quarterly basis, Construction in Progress rose 55.22% year-over-year to $104.0 million in Q4 2022; TTM through Dec 2022 was $104.0 million, a 55.22% increase from a year earlier, with the FY2022 full-year figure at $104.0 million, up 55.22% from the prior year.
- Construction in Progress was $104.0 million for Q4 2022 at Instil Bio, up from $67.0 million in the prior quarter.
- The five-year high for Construction in Progress was $104.0 million in Q4 2022, with the low at $6.3 million in Q4 2020.
- Average Construction in Progress over 3 years is $48.8 million, with a median of $44.2 million recorded in 2021.
- The sharpest annual moves came in 2021 and 2022: Construction in Progress surged 963.49% in 2021, then surged 55.22% in 2022.
- Over 3 years, Construction in Progress stood at $6.3 million in 2020, then soared by 963.49% to $67.0 million in 2021, then soared by 55.22% to $104.0 million in 2022.
- The last three Construction in Progress figures came in at $104.0 million (Q4 2022), $67.0 million (Q4 2021), and $44.2 million (Q3 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Instil Bio | 50.19 Mn | 50.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 104.00 Mn |
| Dec 31, 2021 | 67.00 Mn |
| Sep 30, 2021 | 44.20 Mn |
| Jun 30, 2021 | 22.60 Mn |
| Dec 31, 2020 | 6.30 Mn |